O-1057

O-1057

Identifiers
IUPAC name 3-(5'-cyano-1',1'-dimethylpentyl)-1-(4-N-morpholinobutyryloxy)-Δ8-tetrahydrocannabinol
PubChem (CID)	9829239
ChemSpider	8004975
Chemical and physical data
Formula	C32H46N2O4
Molar mass	522.717 g/mol
3D model (Jmol)	Interactive image
SMILES N#CCCCCC(c3cc1OC([C@@H]4C/C=C(\CC4c1c(OC(=O)CCCN2CCOCC2)c3)C)(C)C)(C)C
InChI InChI=1S/C32H46N2O4/c1-23-11-12-26-25(20-23)30-27(37-29(35)10-9-15-34-16-18-36-19-17-34)21-24(22-28(30)38-32(26,4)5)31(2,3)13-7-6-8-14-33/h11,21-22,25-26H,6-10,12-13,15-20H2,1-5H3/t25-,26-/m1/s1 Key:YRDNBEPFVBMTNP-CLJLJLNGSA-N
(verify)

O-1057 is an analgesic cannabinoid derivative created by Organix Inc., Newburyport, Massachusetts, for use in scientific research. Unlike most cannabinoids discovered to date, it is water-soluble, which gives it considerable advantages over many related cannabinoids. It has moderate affinity for both CB₁ and CB₂ receptors, with K_i values of 8.36 nM at CB₁ and 7.95 nM at CB₂.

See also

• AM-2232
• O-774
• O-1812
• O-2694